Nishida H

No ORCID on file · 7 papers in corpus · active 2021-2025

Study types

  • case-report 2
  • article 1

Condition tags

  • adenomyosis 2
  • endometriosis 1
  • chronic_pelvic_pain 1
2025
NDD-ECHO: A standardised digital assessment tool to capture early life environmental and inflammatory factors for children with neurodevelopmental disorders.
Brain, behavior, & immunity - health ·doi:10.1016/j.bbih.2025.101011

Neurodevelopmental disorders (NDDs), such as autism spectrum disorder (ASD), attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), and Tourette syndrome are highly prevalent in childhood and are influenced by…

case-report 2025
Sequential therapy of dienogest following relugolix for adenomyosis and impact on symptoms and serum CA125 levels: a case series
BMC women's health ·doi:10.1186/s12905-025-03681-8

BACKGROUND: Adenomyosis, characterized by endometrial tissue within the uterine muscle, often presents with severe pelvic pain and menorrhagia. This case series demonstrates the efficacy of sequential therapy involving relugolix followed by…

2024
Large cervical endometrioid adenocarcinoma mimicking endometrial endometrioid adenocarcinoma: A case report.
Radiology case reports ·doi:10.1016/j.radcr.2024.09.037

Endometrioid adenocarcinoma of the uterine cervix is rare and difficult to distinguish from endometrial adenocarcinoma, particularly in large bulky cases. Herein, we report a rare case of a large endometrioid adenocarcinoma in a 58-year-old…

2024
Prognostic analysis of peritoneal washing cytology during interval debulking surgery in advanced ovarian cancer.
Journal of ovarian research ·doi:10.1186/s13048-024-01494-1

BackgroundInterval debulking surgery (IDS) following neoadjuvant chemotherapy is a treatment option for advanced ovarian cancer. Optimal surgery is required for better survival; however, while peritoneal washing cytology (PWC) has been iden…

2022
Case report: Posterior reversible encephalopathy syndrome, an adverse effect of lenvatinib and pembrolizumab combination therapy, in a patient with advanced endometrial cancer.
Frontiers in oncology ·doi:10.3389/fonc.2022.1079716

BackgroundLenvatinib-pembrolizumab combination (LEAP) is an approved therapy in Japan for advanced endometrial cancer, based on the data from the KEYNOTE-775 clinical trial. We report a case of posterior reversible encephalopathy syndrome (…

article 2021
A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy
BMC women's health ·doi:10.1186/s12905-021-01442-x

Abstract Background Recently, relugolix, an oral gonadotropin-releasing hormone receptor antagonist, has been considered an effective therapy for leiomyoma based on a phase 3 study in Japanese women. Leiomyoma combined with severe adenomyos…

case-report 2021
CT, MRI, and FDG-PET imaging findings of low-grade extrauterine endometrial stromal sarcoma arising from the mesentery: A case report
Radiology case reports ·doi:10.1016/j.radcr.2021.06.063

Endometrial stromal sarcoma is a rare uterine mesenchymal neoplasm, and extrauterine endometrial stromal sarcoma is even rarer, with a limited number of case reports. In the present report, we present a case of low-grade extrauterine endome…